NCT04476355

Brief Summary

Physical restraints (PR) are widely used in ICU around the world. Many institutions have suggested that the use of PR should be reduced. Clinical practice guidelines (CPGs) are a convenient way of packaging evidence and presenting recommendations to healthcare decision makers. There are currently no CPGs on PR in China, while other countries had, so we hope to be able to adapt existing guidelines to apply in Chinese context. We use the CAN-IMPLEMENT approach to adapt and implement the guidelines.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
204

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

March 31, 2022

Status Verified

June 1, 2021

Enrollment Period

6 months

First QC Date

June 28, 2020

Last Update Submit

March 28, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • rate of utilization of physical restraints

    Length of utilization of physical restraints / length of stay in ICU

    2 years

Study Arms (2)

control group

NO INTERVENTION

In the same ICU, the former(2019-12\~2020-12) patients were the control group, data collected through case system.

experimental group

EXPERIMENTAL

In the same ICU, the patients in the study period were the experimental group

Other: Select and Tailor implementation interventions

Interventions

Based on previously adapted guidelines and the assessment of innovation, adopters and practice environment for barriers and supports, the interventions mainly include patients education, practioners education and system changes.

experimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient him/herself or the patient's authorized agent signed the informed consent to the study

You may not qualify if:

  • Patients with a history of basic mental illness or cognitive impairment before admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310009, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: In the same ICU, the patients in the study period were the experimental group and the former patients were the control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2020

First Posted

July 20, 2020

Study Start

September 1, 2021

Primary Completion

March 1, 2022

Study Completion

December 1, 2022

Last Updated

March 31, 2022

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

The data analyzed in this study is not included in a repository because it contains interview transcripts.

Locations